Clearpoint Neuro, Inc. (CLPT)
13.36
-0.33
(-2.41%)
USD |
NASDAQ |
Dec 09, 10:54
Clearpoint Neuro EPS Diluted (Quarterly): -0.2072 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.0704 |
| Masimo Corp. | -1.859 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.891M |
| Revenue (Quarterly) | 8.861M |
| Total Expenses (Quarterly) | 14.75M |
| Enterprise Value | 386.64M |
| Gross Profit Margin (Quarterly) | 63.20% |
| Profit Margin (Quarterly) | -66.48% |
| Earnings Yield | -6.18% |
| Normalized Earnings Yield | -6.184 |